Task: Answer the multiple-choice question.
Query: Which drug exhibits a -35.720% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) COc1ccc(CNc2nc3c(c(=O)[nH]c(=O)n3C)n2CCCc2ccccc2)cc1
b) Cc1ccc(S(=O)(=O)N2CCN(c3ncnc4sccc34)CC2)cc1
Answer: b. Cc1ccc(S(=O)(=O)N2CCN(c3ncnc4sccc34)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCN(c3ncnc4sccc34)CC2)cc1
Cc1ccc(S(=O)(=O)N2CCN(c3ncnc4sccc34)CC2)cc1
4-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]thieno[2,3-d]pyrimidine